Sun Pharmaceutical Industries shares fall and underperform competitors
Updated
Updated · MarketWatch · May 7
Sun Pharmaceutical Industries shares fall and underperform competitors
11 articles · Updated · MarketWatch · May 7
The stock slipped 0.86% to 1,834.40 rupees on Thursday as India's BSE Sensex fell 0.15% to 77,844.52.
Sun Pharma closed 1.27% below its 52-week high of 1,857.95 rupees, reached on 6 May.
It lagged peers, with Zydus Lifesciences up 0.16%, while Shilpa Medicare fell 0.05% and Dr Reddy's Laboratories dropped 0.26%; volume was 161,036, near its 50-day average.
While Sun Pharma pursues a mega-deal, are nimbler rivals like Zydus and Shilpa better positioned for immediate growth?
Is Sun Pharma's record $11.75B acquisition a strategic masterstroke or a debt-laden trap under new US tariffs?